Original site: www.cdc.gov/mrsa/hcp/clinical-overview/index.html | RestoredCDC.org is an independent project, not affiliated with CDC or any federal entity. Visit CDC.gov for free official information. Due to archival on January 6, 2025, recent outbreak data is unavailable. Videos are not restored. Access data.restoredcdc.org for restored data. Use of this site implies acceptance of this disclaimer.

[More]
About Us Report Bug

RestoredCDC.org Comparison

Comparison timestamp: 2025-05-05 19:13:37 UTC
RestoredCDC URL: http://restoredcdc.org/www.cdc.gov/mrsa/hcp/clinical-overview/index.html
Live cdc.gov URL ↗: https://www.cdc.gov/mrsa/hcp/clinical-overview/index.html
Removed: Line removed from cdc.gov. Specific word removals are highlighted.
Added: Line added to cdc.gov. Specific word additions are highlighted.
Injected: Line or disclaimer added by RestoredCDC.org.
Unchanged: Line unchanged.
Original site: www.cdc.gov/mrsa/hcp/clinical-overview/index.html | RestoredCDC.org is an independent project, not affiliated with CDC or any federal entity. Visit CDC.gov for free official information. Due to archival on January 6, 2025, recent outbreak data is unavailable. Videos are not restored. Access data.restoredcdc.org for restored data. Use of this site implies acceptance of this disclaimer.
[More]
About Us Report Bug Compare Content
Skip directly to site content Skip directly to search Skip directly to On This Page
An official website of the United States government
Here's how you know
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.
Methicillin-resistant Staphylococcus aureus (MRSA)
Explore Topics
Search
Search
Clear Input
For Everyone
* Basics
* Prevention
* Resources
* View all
Health Care Providers
* Clinician Brief
* Infection Control Guidance
* View all
Public Health
* Lab Testing
* View all
Related Topics:
Healthcare-Associated Infections (HAIs)
View All
search close search
search
MRSA Menu Close
MRSA Menu
search
For Everyone
* Basics
* Prevention
* Resources
* View All
Health Care Providers
* Clinician Brief
* Infection Control Guidance
* View All
Public Health
* Lab Testing
* View All
Related Topics
* Healthcare-Associated Infections (HAIs)
View All MRSA
Clinician Brief Infection Control Guidance View All
April 12, 2024
Clinical Overview of Methicillin-resistant Staphylococcus aureus (MRSA) in Healthcare Settings
At a glance
* MRSA can cause severe problems in healthcare facilities.
* MRSA can be resistant to several antibiotics.
* MRSA prevention efforts can reduce infections.
Overview
CDC considers methicillin-resistant Staphylococcus aureus (MRSA) a "serious threat."1 In healthcare facilities, such as hospitals or nursing homes, MRSA can cause severe problems including:
* Bloodstream infections
* Pneumonia
* Surgical site infections
* Sepsis
* Death
CDC encourages clinicians to consider MRSA in the diagnosis of skin and soft tissue infections (SSTIs) compatible with S. aureus infections, especially those that are purulent (e.g., fluctuant or palpable fluid-filled cavity, yellow or white center, central point or "head," draining pus, or possible to aspirate pus with needle or syringe).
Risk factors
People are at higher risk for MRSA infection when they:
* Have surgery.
* Have medical devices inserted in their body.
* Use needles to inject drugs.
How it spreads
In healthcare settings, MRSA usually spreads through direct contact with an infected wound or from contaminated hands. People who carry MRSA but do not have signs of infection (i.e., people who are colonized) can spread the bacteria to others.
How common it is
Studies show that about one in three people (33%) carry S. aureus bacteria in their nose (the main site of colonization), usually without any illness. About two in every 100 people (2%) carry MRSA, although this may be higher in certain populations. Although many people carry MRSA bacteria in their nose, most do not develop serious MRSA infections.
Skin infections caused by MRSA are common in the general community.
Resource‎
Information about MRSA rates in U.S. hospitals is available through the National Healthcare Safety Network (NHSN).
Clinical features
Most S. aureus skin infections, including MRSA, appear as a bump or infected area on the skin that might be:
* Red.
* Swollen.
* Painful.
* Warm to the touch.
* Full of pus or other drainage.
* Accompanied by a fever.
A patient presenting with a "spider bite" should raise suspicion of an S. aureus infection, including MRSA.
SSTIs, carbuncles and abscesses are the most reported clinical manifestations.
The role of MRSA in cellulitis without abscess or purulent drainage is less clear since cultures are rarely obtained.
Prevention
Numerous studies show that MRSA prevention efforts can reduce infections.
Successful MRSA prevention requires action at the healthcare facility level, among both healthcare providers and leadership. See CDC's strategies to prevent S. aureus in acute care facilities and Society for Healthcare Epidemiology of America (SHEA)/Infectious Diseases Society of America (IDSA)/Association for Professionals in Infection Control and Epidemiology (APIC) Practice Recommendation.
Keep Reading: Infection Control Guidance: Preventing Methicillin-resistant Staphylococcus aureus (MRSA) in Healthcare Facilities
Testing
Providers can test some patients to see if they carry MRSA in their nose or on their skin. This test involves rubbing a cotton-tipped swab in the patient's nostrils or on the skin.
The only way to know if MRSA is the cause of an infection is to test for the bacteria in a laboratory.
Keep Reading: Laboratory Testing for Methicillin (oxacillin)-resistant Staphylococcus aureus (MRSA)
Treatment and recovery
Expand All
Treatment and decolonization
The main treatment for MRSA skin infections is incisions and drainage. Antibiotics may also be required. Providers can also apply topical medicines and antiseptics to decrease the amount of S. aureus on a person's body.
Antibiotics
Culture and susceptibility testing should guide therapy and antibiotic decisions for patients with severe infections that do not respond to initial treatment attempts.
Complications
MRSA skin infections can develop into more serious infections. It is important to discuss a follow-up plan with your patients in case they develop symptoms, or if symptoms do not improve within 48 hours.
Resources and tools
Guidelines
* Outpatient management of SSTIs in the era of community-associated MRSA.
+ Poster (Print Only)
+ Factsheet (Print Only)
* Clinical Practice Guidelines by the IDSA for the Treatment of MRSA Infections in Adults and Children (2011)
* Infectious Diseases Society of America (IDSA)
Additional resources
* Prevent Bacterial and Fungal Infections in Patients who Inject Drugs
Factsheets for clinicians
Factsheets & Posters
Factsheets, posters, and more for MRSA awareness.
Mar. 19, 2024
On This Page
* Overview
* Risk factors
* How it spreads
* How common it is
* Clinical features
* Prevention
* Testing
* Treatment and recovery
* Complications
* Resources and tools
Related PagesInfection Control Guidance
Related Pages
*
Back to Top
* Infection Control Guidance
View All MRSA
Infection Control Guidance
April 12, 2024
Sources Print Share
Facebook LinkedIn Twitter Syndicate
Content Source:
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
References
1. https://www.cdc.gov/drugresistance/biggest-threats.html
Related PagesInfection Control Guidance
Related Pages
*
 
* Infection Control Guidance
View All MRSA
Back to Top
MRSA
MRSA is a germ that is resistant to some antibiotics. It can spread in hospitals, other healthcare facilities, and in the community.
View All
For Everyone
* Basics
* Prevention
* Resources
Health Care Providers
* Clinician Brief
* Infection Control Guidance
Public Health
* Lab Testing
Sign up for Email Updates
Contact Us
Contact Us
* Call 800-232-4636
* Contact CDC
About CDC
About CDC
* Pressroom
* Organization
* Budget & Funding
* Careers & Jobs
Policies
* Accessibility
* External Links
* Privacy
* Web Policies
* FOIA
* OIG
* No Fear Act
* Nondiscrimination
* Vulnerability Disclosure Policy
Languages
Languages
* Español
Language Assistance
* Español
* 繁體中文
* Tiếng Việt
* 한국어
* Tagalog
* Русский
* العربية
* Kreyòl Ayisyen
* Français
* Polski
* Português
* Italiano
* Deutsch
* 日本語
* فارسی
* English
Archive
* CDC Archive
* Public Health Publications
Contact Us
Contact Us
* Call 800-232-4636
* Contact CDC
About CDC
* Pressroom
* Organization
* Budget & Funding
* Careers & Jobs
* About CDC
Policies
* Accessibility
* External Links
* Privacy
* Web Policies
* FOIA
* OIG
* No Fear Act
* Nondiscrimination
* Vulnerability Disclosure Policy
Languages
Languages
* Español
Language Assistance
* Español
* 繁體中文
* Tiếng Việt
* 한국어
* Tagalog
* Русский
* العربية
* Kreyòl Ayisyen
* Français
* Polski
* Português
* Italiano
* Deutsch
* 日本語
* فارسی
* English
Archive
* CDC Archive
* Public Health Publications
HHS.gov USA.gov
Note: Comparison ignores leading/trailing whitespace and certain script/tracking codes. Word-level highlighting (optional above) only applies to changed lines.